Global Hirudin Market - Industry Analysis Size Share Growth Trends and Forecast 2024 - 2031

Product Description

Hirudin is a naturally occurring peptide in the salivary glands of blood-sucking leeches that has a blood anticoagulant property. This is fundamental for the leeches’ alimentary habit of hematophagy, since it keeps the blood flowing after the initial phlebotomy performed by the worm on the host’s skin. The Hirudin market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031. Considering the influence of COVID-19 on the global Hirudin market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions. This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery. Under COVID-19 Outbreak, how the Hirudin Industry will develop is also analyzed in detail in Chapter 1.8 of this report. Major Players in Hirudin market are: Mitsubishi Tanabe Pharma Corporation Sanofi S.A. Abbott India Limited Bayer Healthcare AG Eisai Inc. Bristol-Myers Squibb Company GlaxoSmithKline Plc. Aspen Holdings Teva Pharmaceutical Industries Ltd. Boehringer Ingelheim Pfizer, Inc. Most important types of Hirudin products covered in this report are: Natural Hirudin Recombinant Hirudin Most widely used downstream fields of Hirudin market covered in this report are: Myocardial infarction Cerebral thrombosis Stroke Skin hematomas Varicose veins Application cream Major Regions or countries covered in this report: North America Europe China Japan Middle East and Africa South America India South Korea Southeast Asia Others In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations. In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out. In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.